Birds's Eye
Technicals
MovingAverage
Candlestick
PivotPoint
Fin Statements
Beta&Vols
Tech ChartsFundamental Analysis of Rossari Biotech Ltd. - Growth / Value Index
ROSSARI - Valuation Highlights
Valuation Analysis
Tremendous increasing in Book Value last 3 year
Tsr Value Index - Poor Score of 27.78
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Price to Earning | 27.49 | 24.52 | -14.27 % | ||
| Price to Book | 3.40 | 2.82 | -20.93 % | 3.17 | |
| Price to Sales | 1.80 | 1.61 | -21.27 % | ||
| Enterprise Value to EBITDA Multiple | 12.99 | -12.55 % |
ROSSARI - Profitability Highlights
Profitability Analysis
Piotroski F Score - Stable Value of 5.0
Annual Net Profit in last 3 years is trending up
EBITDA is continuously increasing for last 3 Years
Good Return on Equity of 12.36% is achieved by the company
Very Low Dividend Yield of 0.070 %
Low Earning Yield of 3.64 %
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Return On Equity | 12.36 | 11.50 | -7.77 % | 2.91 | |
| Return On Asset | 8.06 | 7.19 | -13.48 % | 1.82 | |
| Net Profit Margin | 6.56 | 6.56 | -8.17 % | 5.94 | |
| Operating Profit Margin | 53.97 | 8.66 | -6.73 % | 11.99 | |
| EBITDA Margin | 12.98 | 12.94 | -7.94 % | 12.32 |
Highlights
| Market Cap | 37539.42 M |
| Enterprise Value | 39054.29 M |
| Price/Book TTM | 3.40 |
| Outstanding Share | 55363.80 K |
| Float/ Outstanding Share | 31.83% |
| Dividend Yield | 0.070 % |
Share Holding
Guru Numbers
| Price/Graham No | 1.97 |
| Peter Lynch Ratio | 0.152 |
| Piotroski F Score | 5.00 |
| Altman Z Score | 5.45 |
| Sloan Ratio | 0.096 |
| Peter Lynch Fair Value | 491.46 |
ROSSARI - Growth Highlights
Growth Analysis
Short term positive trend in total sale and net profit
Tremendous increasing trend in total sale last 3 year
Quarterly sales in last 5 years is trending up
Steady increase in Total Assets for last 3 Years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 2080.29 (Cr) | 13.64 % | 13.03 % |
| Gross Profit | 574.18 (Cr) | 15.80 % | 6.07 % |
| EBITDA | 270.06 (Cr) | 4.62 % | 8.81 % |
| Net Profit | 136.37 (Cr) | 4.35 % | 8.64 % |
| EPS | 24.66 | 4.18 % | NA |
ROSSARI - Stability Highlights
Stability Analysis
Tsr Stability Index - Good Score of 76.56
Altman Z Score of 5.45 suggests good Stability
Company is unable to generate enough free cash to support the business.
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|
| Debt to Equity Ratio | 0.165 | 60.32 % | 0.165 | |
| Cash Ratio | 0.107 | 49.77 % | ||
| Quick Ratio | 1.28 | -3.17 % | 1.28 | |
| Shareholders Equity | 62.52 | -6.19 % | ||
| Debt to EBITDA | 0.727 | 73.38 % |
Historical Valuation Ratios of Rossari Biotech Ltd.
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Rossari Biotech Ltd.
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Rossari Biotech Ltd.
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Rossari Biotech Ltd.
Historical Solvency Ratios
Loading ...